4.7 Review

The Role of the Innate Immune Response in Oral Mucositis Pathogenesis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study

Ghanyah Al-Qadami et al.

Summary: This study aimed to uncover associations between an individual's pre-therapy gut microbiota and the severity of radiotherapy-induced oral mucositis (OM) as well as recurrence risk in patients with head and neck cancer (HNC). The results showed that the composition of the gut microbiota was associated with the severity of OM and the risk of HNC recurrence.

SUPPORTIVE CARE IN CANCER (2023)

Review Cell Biology

Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health

Chiara Mazziotta et al.

Summary: Immune cells and commensal microbes in the human intestine communicate and react with each other to maintain healthy immune activities. Probiotic bacteria can stimulate immune cells and microflora to modulate immune functions and homeostasis. The use of probiotics has potential for improving immune system activities.
Article Pharmacology & Pharmacy

Anakinra and dexamethasone treatment of idarubicin-induced mucositis and diarrhoea in rats

Fredrik Kullenberg et al.

Summary: Chemotherapy-induced mucositis is a severe side effect in cancer patients, for which there is currently no effective supportive therapy. This study investigated the use of anakinra and dexamethasone as potential treatments for idarubicin-induced mucositis in rats. The results showed that anakinra alone can reverse the induced diarrhea and a combination of anakinra and dexamethasone can prevent the reduction of jejunal villus height. These findings suggest that anakinra and dexamethasone may serve as supportive therapies for chemotherapy-induced intestinal mucositis and diarrhea.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2023)

Review Immunology

The interaction between innate immunity and oral microbiota in oral diseases

Hongzhi He et al.

Summary: The interaction between oral microbiota and innate immunity plays a vital role in the pathogenesis and development of oral diseases. Understanding the mechanisms of this interaction can lead to the development of novel therapies for preventing and treating oral diseases.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Review Biochemistry & Molecular Biology

From Pathogenesis to Intervention: The Importance of the Microbiome in Oral Mucositis

Julia S. Bruno et al.

Summary: Oral mucositis (OM) is a common and impactful toxicity of standard cancer therapy, largely caused by the destruction of epithelial cells and increased inflammation. Changes in the oral microbiome may contribute to the development and severity of OM, beyond opportunistic infections. This review analyzes the bacterial shift in cancer patients with OM through 16S rRNA gene sequencing, and explores the potential role of the patient's microbial fingerprint in OM development and prediction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Anti-Inflammatory Effects of β-Cryptoxanthin on 5-Fluorouracil-Induced Cytokine Expression in Human Oral Mucosal Keratinocytes

Hironaka Yamanobe et al.

Summary: Oral mucositis, a common side effect of chemotherapy, causes oral pain and affects patients' quality of life. The effects of beta-cryptoxanthin (beta-cry), a carotenoid found in citrus fruits with antioxidant and anti-inflammatory properties, on oral mucositis are unclear. In this study, we found that beta-cry can enhance cell proliferation and suppress the expression of inflammatory cytokines and matrix metalloproteinases induced by 5-fluorouracil (5-FU) in human normal oral mucosal keratinocytes (hOMK). These findings suggest that beta-cry can alleviate chemotherapy-induced oral mucositis when combined with oral care.

MOLECULES (2023)

Article Nursing

Nurses' knowledge on assessment and management of cancer therapy-associated oral mucositis

Barnabas Manlokiya Raymond et al.

Summary: This study explored the baseline nursing knowledge on assessment and management of cancer therapy-associated oral mucositis (OM) in a tertiary hospital in Ghana. The findings revealed that nurses had insufficient knowledge on the standardized tool for OM assessment and lacked a definitive approach to prevent and treat OM. Insufficient knowledge on cancer treatment-associated mucositis, lack of structured protocol for OM, and unavailable tools for assessing the oral mucosa were identified as factors affecting the management of OM.

NURSING OPEN (2023)

Article Multidisciplinary Sciences

Supporting the gastrointestinal microenvironment during high-dose chemotherapy and stem cell transplantation by inhibiting IL-1 signaling with anakinra

H. R. Wardill et al.

Summary: High-dose chemotherapy can cause intestinal inflammation and breakdown of the mucosal barrier, leading to translocation of enteric pathogens. Antibiotics, the main treatment for these complications, have been found to have detrimental effects. This study shows that anakinra, an IL-1RA inhibitor, can minimize mucosal barrier injury and clinical symptoms in rats. The use of anakinra also leads to a more stable fecal microbiome composition. Additionally, anakinra has been proven safe in stem cell transplant patients. These results suggest that strengthening the mucosal barrier may be an effective strategy to mitigate the clinical consequences of high-dose chemotherapy.

SCIENTIFIC REPORTS (2022)

Review Immunology

Roles of Toll-Like Receptors in Radiotherapy- and Chemotherapy-Induced Oral Mucositis: A Concise Review

Ling Ji et al.

Summary: Radiotherapy and/or chemotherapy-induced oral mucositis (RIOM/CIOM) is a common complication in cancer patients. TLRs have a significant role in RIOM/CIOM and may serve as a novel mechanism for therapeutic interventions.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Oncology

Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

Mitchell S. von Itzstein et al.

Summary: Patients treated with antibiotics have worse outcomes from cancer immunotherapy, potentially due to the impact of antibiotics on the gut microbiome. This study found significant differences in immune parameters, including antibodies and cytokines, according to antibiotic exposure.

CANCERS (2022)

Article Immunology

Distinctive microbiota of delayed healing of oral mucositis after radiotherapy of nasopharyngeal carcinoma

Rui Jiang et al.

Summary: This study suggests a potential association between oral microbiome and delayed healing of oral mucositis in patients with nasopharyngeal carcinoma (NPC). Actinobacteria and Veillonellaceae may serve as biomarkers to predict the risk of severe delayed healing of oral mucositis after radiotherapy.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Veterinary Sciences

Clinical evaluation of toll-like receptor-5 agonist for radiation-induced oral mucositis in beagle dogs

Jaeeun Ko et al.

Summary: This study evaluated the clinical safety and radiomitigative effect of KMRC011 in beagle dogs with radiation-induced oral mucositis. The results suggest that KMRC011 may be used as an adjuvant for short-term radiotherapy without severe adverse effects.

FRONTIERS IN VETERINARY SCIENCE (2022)

Article Biochemistry & Molecular Biology

The Effect of Intensity-Modulated Radiotherapy to the Head and Neck Region on the Oral Innate Immune Response and Oral Microbiome: A Prospective Cohort Study of Head and Neck Tumour Patients

Zahra Dorna Mojdami et al.

Summary: This study aimed to investigate the effects of radiation therapy (RT) on oral neutrophils (oPMNs) and the oral microbiome in patients undergoing head and neck tumor (HNT) treatment. The results showed that RT caused a significant decrease in oPMN counts and suppressed their activation state, while also altering the composition of the oral microbiome.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Dentistry, Oral Surgery & Medicine

Precision medicine for risk prediction of oral complications of cancer therapy-The example of oral mucositis in patients receiving radiation therapy for cancers of the head and neck

Stephen T. Sonis

Summary: Oral complications of cancer therapy are common and affect patients' quality of life. Risk factors impact treatment outcomes and precision medicine can help optimize treatment plans by considering individualized response to specific treatments.

FRONTIERS IN ORAL HEALTH (2022)

Review Dentistry, Oral Surgery & Medicine

Oral-Gut Microbiome Axis in the Pathogenesis of Cancer Treatment-Induced Oral Mucositis

Ghanyah Al-Qadami et al.

Summary: Oral mucositis is a common and debilitating complication of cancer treatments, causing pain and impairing oral functions, which can lead to treatment interruption and negative impacts on quality of life and tumor prognosis. Understanding the pathogenesis of OM helps identify new targets for intervention or prevention, with the oral-gut microbiome axis playing an important role in the development of OM.

FRONTIERS IN ORAL HEALTH (2022)

Review Cell Biology

Site-specific contribution of Toll-like receptor 4 to intestinal homeostasis and inflammatory disease

Elise E. Bruning et al.

Summary: TLR4 is a highly conserved protein involved in innate immunity with distinct roles in epithelial and immune cells throughout the gastrointestinal tract. While epithelial cell expression of TLR4 contributes to maintaining homeostasis, promoting immunoglobulin A production, and regulating permeability, immune cell expression is centered on maturation of dendritic cells and priming the adaptive immune system. However, further research is needed to fully understand the impact of site-specific TLR4 expression on inflammation and disease progression.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Medicine, Research & Experimental

Neutrophil elastase inhibitor (MPH-966) improves intestinal mucosal damage and gut microbiota in a mouse model of 5-fluorouracil-induced intestinal mucositis

Kung-Ju Chen et al.

Summary: The study indicated that the overexpression of neutrophil elastase (NE) is a key feature in 5-FU-induced intestinal mucositis (FUIIM). Treatment with the specific NE inhibitor MPH-966 significantly reversed the adverse effects of 5-FU on body weight, food intake, and intestinal function. MPH-966 also restored the balance of gut microbiota, suggesting its potential as a treatment candidate for FUIIM.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Oncology

A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment

Stephen T. Sonis

Summary: Oral mucositis (OM) is a significant unmet need for patients receiving standard concomitant chemoradiation (CRT) regimens for head and neck cancers, with a complex pathogenesis involving oxidative stress. A hypothesis suggests that the mucosal damage in OM is mainly due to cumulative CRT-induced biological changes overwhelming physiological self-protective mechanisms, and an individual's ability to mount a protective response is determined by interactions between genomics, epigenomics, and microbiomics. Effective biologic or pharmacologic interventions for OM are likely to supplement or stimulate existing physiological damage-control mechanisms.

SUPPORTIVE CARE IN CANCER (2021)

Review Chemistry, Medicinal

Superoxide Dismutase as an Intervention for Radiation Therapy-Associated Toxicities: Review and Profile of Avasopasem Manganese as a Treatment Option for Radiation-Induced Mucositis

Stephen T. Sonis

Summary: Toxicities associated with radiation therapy can be effectively mitigated through interventions aimed at disrupting the biological cascade of toxicity development, with oxidative stress being a key initiator of normal tissue injury. Attempts to supplement endogenous superoxide dismutases or develop synthetic dismutase mimetics have shown some potential, with avasopasem manganese emerging as a promising dismutase mimetic in clinical trials for reducing severe oral mucositis in head and neck cancer patients undergoing chemoradiation.

DRUG DESIGN DEVELOPMENT AND THERAPY (2021)

Article Medicine, General & Internal

Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy

Iwona Homa-Mlak et al.

Summary: The study revealed a positive correlation between NLR and the severity of OM, with higher NLR values associated with an increased risk of more severe OM. Additionally, higher TNM stage and NLR values were identified as independent prognostic factors for survival.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Multidisciplinary Sciences

GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling

Abigail Pulsipher et al.

Summary: Radiation therapy causes tissue damages, leading to increased expression levels of PRRs and pro-inflammatory cytokine genes. GM-1111 significantly reduces the severity and incidence of OM by inhibiting downstream pro-inflammatory cytokine genes, without interfering with radiation therapy for HNC SCC-25 tumor regression.

PLOS ONE (2021)

Review Biochemistry & Molecular Biology

An Overview of Physical, Microbiological and Immune Barriers of Oral Mucosa

Sevda Senel

Summary: The oral mucosa, as the lining tissue of the oral cavity, serves as a critical barrier against pathogens and exogenous chemicals. The oral microbiota and immune system play vital roles in maintaining host health through interactions that affect homeostasis and disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

Tissue Damage in Radiation-Induced Oral Mucositis Is Mitigated by IL-17 Receptor Signaling

Jessica Saul-McBeth et al.

Summary: Oral mucositis (OM) is a treatment-limiting adverse side effect of radiation and chemotherapy, with approximately 80% of patients undergoing radiotherapy for head and neck cancers developing OM. Studies suggest that IL-17 plays a protective role in OM through multiple mechanisms including restoration of damaged epithelia and control of neutrophil response.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Oral microbiota transplantation fights against head and neck radiotherapy-induced oral mucositis in mice

Huiwen Xiao et al.

Summary: Oral mucositis is a common complication in NOALC patients undergoing radiotherapy, and oral microbiota transplantation can alleviate the symptoms. The gut microbiota also plays a role in oral mucositis progression. Additionally, specific oral microorganisms like Lactobacillaceae could potentially serve as biomarkers for predicting NOALC prognosis after radiotherapy.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Review Biochemistry & Molecular Biology

Toll-like Receptors and the Control of Immunity

Katherine A. Fitzgerald et al.

Review Oncology

Oral mucositis: the hidden side of cancer therapy

Claudio Pulito et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Review Cell Biology

Emerging connectivity of programmed cell death pathways and its physiological implications

Sammy Bedoui et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Oncology

Understanding and Overcoming the Inflammatory Toxicities of Immunotherapy

Michael Dougan

CANCER IMMUNOLOGY RESEARCH (2020)

Review Oncology

Targeting immunogenic cell death in cancer

Asma Ahmed et al.

MOLECULAR ONCOLOGY (2020)

Article Medicine, Research & Experimental

IL-1β strengthens the physical barrier in gingival epithelial cells

Kim Natalie Stolte et al.

TISSUE BARRIERS (2020)

Article Veterinary Sciences

Effects of anakinra on the small intestine mucositis induced by methotrexate in rats

Fatih Ozcicek et al.

EXPERIMENTAL ANIMALS (2020)

Article Immunology

Commensal and Pathogenic Biofilms Alter Toll-Like Receptor Signaling in Reconstructed Human Gingiva

Lin Shang et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Article Dentistry, Oral Surgery & Medicine

Change of saliva composition with radiotherapy

Vera J. Mueller et al.

ARCHIVES OF ORAL BIOLOGY (2019)

Review Medicine, Research & Experimental

The role of NLRP3 inflammasome activation in radiation damage

Jinlong Wei et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Immunology

Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis

Keon-Il Im et al.

MUCOSAL IMMUNOLOGY (2019)

Review Immunology

Oral Mucosal Epithelial Cells

Sabine Groeger et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Cell Biology

Interactions between the microbiota and innate and innate-like lymphocytes

Michael G. Constantinides

JOURNAL OF LEUKOCYTE BIOLOGY (2018)

Review Nutrition & Dietetics

Toll-Like Receptors: Regulators of the Immune Response in the Human Gut

Hubert Hug et al.

NUTRIENTS (2018)

Review Dermatology

Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails

Mario Lacouture et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)

Article Multidisciplinary Sciences

GAS6 is a key homeostatic immunological regulator of host-commensal interactions in the oral mucosa

Maria Nassar et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Health Care Sciences & Services

Advances in the understanding and management of mucositis during stem cell transplantation

Joanne M. Bowen et al.

CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2017)

Article Oncology

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy

Paolo Bossi et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

Review Dentistry, Oral Surgery & Medicine

Host-Microbiome Cross-talk in Oral Mucositis

R. M. Vasconcelos et al.

JOURNAL OF DENTAL RESEARCH (2016)

Review Multidisciplinary Sciences

The microbiome and innate immunity

Christoph A. Thaiss et al.

NATURE (2016)

Review Immunology

Integration of Innate Immune Signaling

Christoph A. Thaiss et al.

TRENDS IN IMMUNOLOGY (2016)

Review Health Care Sciences & Services

Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity

Elke Cario

CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2016)

Review Oncology

Mucositis: pathobiology and management

Alessandro Villa et al.

CURRENT OPINION IN ONCOLOGY (2015)

Review Dentistry, Oral Surgery & Medicine

The role of oral flora in the development of chemotherapy-induced oral mucositis

Andrea M. Stringer et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2015)

Article Dentistry, Oral Surgery & Medicine

TLR2, TLR4 and CD86 gene polymorphisms in recurrent aphthous stomatitis

Jumana Karasneh et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2015)

Article Endocrinology & Metabolism

Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis

Francisco Ortiz et al.

JOURNAL OF PINEAL RESEARCH (2015)

Review Dentistry, Oral Surgery & Medicine

Oral mucosal injury in oncology patients: perspectives on maturation of a field

D. E. Peterson et al.

ORAL DISEASES (2015)

Review Dentistry, Oral Surgery & Medicine

Microbiota and their role in the pathogenesis of oral mucositis

B. Vanhoecke et al.

ORAL DISEASES (2015)

Article Dentistry, Oral Surgery & Medicine

The expression of hBDs in the gingival tissue and keratinocytes from healthy subjects and periodontitis patients

Jiarong Liu et al.

ARCHIVES OF ORAL BIOLOGY (2014)

Article Microbiology

Gut Microbiota Promote Hematopoiesis to Control Bacterial Infection

Arya Khosravi et al.

CELL HOST & MICROBE (2014)

Review Immunology

The interplay between the innate immune system and the microbiota

Christoph A. Thaiss et al.

CURRENT OPINION IN IMMUNOLOGY (2014)

Article Multidisciplinary Sciences

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

Sophie Viaud et al.

SCIENCE (2013)

Review Cell Biology

DAMPening Inflammation by Modulating TLR Signalling

A. M. Piccinini et al.

MEDIATORS OF INFLAMMATION (2010)

Review Immunology

Innate IL-17-producing cells: the sentinels of the immune system

Daniel J. Cua et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Article Infectious Diseases

Mucositis: from febrile neutropenia to febrile mucositis

Nicole M. A. Blijlevens et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)

Article Dentistry, Oral Surgery & Medicine

Histomorphometry and immunohistochemical features of grade I (WHO) oral radiomucositis

P. R. F. Bonan et al.

ORAL DISEASES (2007)

Article Microbiology

Defining the normal bacterial flora of the oral cavity

JA Aas et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2005)

Review Immunology

NLRs join TLRs as innate sensors of pathogens

F Martinon et al.

TRENDS IN IMMUNOLOGY (2005)

Review Oncology

The pathobiology of mucositis

ST Sonis

NATURE REVIEWS CANCER (2004)